BMS CA125-1008: AR degradation in mCRPC patients

Clinical Trial Grant

Duke Scholars

Principal Investigator Andrew John Armstrong Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Bristol-Myers Squibb Company

Start Date

May 27, 2024

End Date

May 19, 2029

Administered By

Duke Cancer Institute

Awarded By

Bristol-Myers Squibb Company

Start Date

May 27, 2024

End Date

May 19, 2029